Cardiac metabolism in patients with dilated and hypertrophic cardiomyopathy: assessment with proton-decoupled P-31 MR spectroscopy

Proton-decoupled phosphorus-31 heart spectroscopy was performed in healthy subjects (n = 9) and patients with dilated cardiomyopathy (DCM, n = 9) or hypertrophic cardiomyopathy (HCM, n = 8). The phosphocreatine (PCr)-to-adenosine triphosphate ratio (+/- one standard deviation) after correction for b...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of magnetic resonance imaging 1992-11, Vol.2 (6), p.711-719
Hauptverfasser: de Roos, A, Doornbos, J, Luyten, P R, Oosterwaal, L J, van der Wall, E E, den Hollander, J A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 719
container_issue 6
container_start_page 711
container_title Journal of magnetic resonance imaging
container_volume 2
creator de Roos, A
Doornbos, J
Luyten, P R
Oosterwaal, L J
van der Wall, E E
den Hollander, J A
description Proton-decoupled phosphorus-31 heart spectroscopy was performed in healthy subjects (n = 9) and patients with dilated cardiomyopathy (DCM, n = 9) or hypertrophic cardiomyopathy (HCM, n = 8). The phosphocreatine (PCr)-to-adenosine triphosphate ratio (+/- one standard deviation) after correction for blood contribution and partial saturation was significantly lower in HCM patients relative to the control subjects (1.32 +/- 0.29 vs 1.65 +/- 0.26, P < .05) but not in DCM patients (1.52 +/- 0.58 vs 1.65 +/- 0.26). The inorganic phosphate (Pi) peak was resolved only in patients with the highest spectral quality. Myocardial pH was lower in HCM patients (n = 6) relative to control subjects (n = 4) (7.07 +/- 0.07 vs 7.15 +/- 0.03, P < .05). The Pi/PCr ratio was higher in DCM (n = 3) and HCM (n = 6) patients relative to control subjects (n = 4) (0.29 +/- 0.06 and 0.20 +/- 0.04, respectively, vs 0.14 +/- 0.06; P < .05). Elevated phosphodiester signal in DCM patients correlated with 2,3-diphosphoglycerate signal (r = .94), reflecting blood pool contamination. P-31 spectroscopy enabled detection of abnormalities in cardiac metabolism and determination of pH in patients with HCM and DCM.
doi_str_mv 10.1002/jmri.1880020616
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_73336337</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>73336337</sourcerecordid><originalsourceid>FETCH-LOGICAL-p138t-1d9b57962540f817cc6b0001dcad36de0d85967e9a30bb2e028f94a1eeb5e1af3</originalsourceid><addsrcrecordid>eNotkD1PwzAQhj2ASinMTEie2FJ8ceIkbKjiSyoCIZgjx74orpLYxK5QVn45Ru10Nzzvo7uXkCtga2Asvd0Nk1lDWcadCRAnZAks5wmUrDgj597vGGNVleULsoAsEwBiSX43ctJGKjpgkI3tjR-oGamTweAYPP0xoaPa9DKgpnLUtJsdTmGyrjOKqv-wHWYb-W6-o9J79H6IyUPQTTbYMdGo7N710fCecKCvH9Q7VFHilXXzBTltZe_x8jhX5Ovx4XPznGzfnl4299vEAS9DArpq8qISaZ6xtoRCKdHEh0ArqbnQyHSZV6LASnLWNCmytGyrTAJikyPIlq_IzcEbr_reow_1YLzCvpcj2r2vC8654LyI4PUR3DcD6tpNZpDTXB9L43-JYnAr</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>73336337</pqid></control><display><type>article</type><title>Cardiac metabolism in patients with dilated and hypertrophic cardiomyopathy: assessment with proton-decoupled P-31 MR spectroscopy</title><source>MEDLINE</source><source>Wiley Journals</source><creator>de Roos, A ; Doornbos, J ; Luyten, P R ; Oosterwaal, L J ; van der Wall, E E ; den Hollander, J A</creator><creatorcontrib>de Roos, A ; Doornbos, J ; Luyten, P R ; Oosterwaal, L J ; van der Wall, E E ; den Hollander, J A</creatorcontrib><description>Proton-decoupled phosphorus-31 heart spectroscopy was performed in healthy subjects (n = 9) and patients with dilated cardiomyopathy (DCM, n = 9) or hypertrophic cardiomyopathy (HCM, n = 8). The phosphocreatine (PCr)-to-adenosine triphosphate ratio (+/- one standard deviation) after correction for blood contribution and partial saturation was significantly lower in HCM patients relative to the control subjects (1.32 +/- 0.29 vs 1.65 +/- 0.26, P &lt; .05) but not in DCM patients (1.52 +/- 0.58 vs 1.65 +/- 0.26). The inorganic phosphate (Pi) peak was resolved only in patients with the highest spectral quality. Myocardial pH was lower in HCM patients (n = 6) relative to control subjects (n = 4) (7.07 +/- 0.07 vs 7.15 +/- 0.03, P &lt; .05). The Pi/PCr ratio was higher in DCM (n = 3) and HCM (n = 6) patients relative to control subjects (n = 4) (0.29 +/- 0.06 and 0.20 +/- 0.04, respectively, vs 0.14 +/- 0.06; P &lt; .05). Elevated phosphodiester signal in DCM patients correlated with 2,3-diphosphoglycerate signal (r = .94), reflecting blood pool contamination. P-31 spectroscopy enabled detection of abnormalities in cardiac metabolism and determination of pH in patients with HCM and DCM.</description><identifier>ISSN: 1053-1807</identifier><identifier>DOI: 10.1002/jmri.1880020616</identifier><identifier>PMID: 1446116</identifier><language>eng</language><publisher>United States</publisher><subject>Adenosine Triphosphate - metabolism ; Adult ; Cardiomyopathy, Dilated - metabolism ; Cardiomyopathy, Hypertrophic - metabolism ; Diphosphoglyceric Acids - metabolism ; Female ; Humans ; Magnetic Resonance Spectroscopy ; Male ; Middle Aged ; Myocardium - metabolism ; Phosphates - metabolism ; Phosphocreatine - metabolism ; Reference Values</subject><ispartof>Journal of magnetic resonance imaging, 1992-11, Vol.2 (6), p.711-719</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1446116$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>de Roos, A</creatorcontrib><creatorcontrib>Doornbos, J</creatorcontrib><creatorcontrib>Luyten, P R</creatorcontrib><creatorcontrib>Oosterwaal, L J</creatorcontrib><creatorcontrib>van der Wall, E E</creatorcontrib><creatorcontrib>den Hollander, J A</creatorcontrib><title>Cardiac metabolism in patients with dilated and hypertrophic cardiomyopathy: assessment with proton-decoupled P-31 MR spectroscopy</title><title>Journal of magnetic resonance imaging</title><addtitle>J Magn Reson Imaging</addtitle><description>Proton-decoupled phosphorus-31 heart spectroscopy was performed in healthy subjects (n = 9) and patients with dilated cardiomyopathy (DCM, n = 9) or hypertrophic cardiomyopathy (HCM, n = 8). The phosphocreatine (PCr)-to-adenosine triphosphate ratio (+/- one standard deviation) after correction for blood contribution and partial saturation was significantly lower in HCM patients relative to the control subjects (1.32 +/- 0.29 vs 1.65 +/- 0.26, P &lt; .05) but not in DCM patients (1.52 +/- 0.58 vs 1.65 +/- 0.26). The inorganic phosphate (Pi) peak was resolved only in patients with the highest spectral quality. Myocardial pH was lower in HCM patients (n = 6) relative to control subjects (n = 4) (7.07 +/- 0.07 vs 7.15 +/- 0.03, P &lt; .05). The Pi/PCr ratio was higher in DCM (n = 3) and HCM (n = 6) patients relative to control subjects (n = 4) (0.29 +/- 0.06 and 0.20 +/- 0.04, respectively, vs 0.14 +/- 0.06; P &lt; .05). Elevated phosphodiester signal in DCM patients correlated with 2,3-diphosphoglycerate signal (r = .94), reflecting blood pool contamination. P-31 spectroscopy enabled detection of abnormalities in cardiac metabolism and determination of pH in patients with HCM and DCM.</description><subject>Adenosine Triphosphate - metabolism</subject><subject>Adult</subject><subject>Cardiomyopathy, Dilated - metabolism</subject><subject>Cardiomyopathy, Hypertrophic - metabolism</subject><subject>Diphosphoglyceric Acids - metabolism</subject><subject>Female</subject><subject>Humans</subject><subject>Magnetic Resonance Spectroscopy</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Myocardium - metabolism</subject><subject>Phosphates - metabolism</subject><subject>Phosphocreatine - metabolism</subject><subject>Reference Values</subject><issn>1053-1807</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1992</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNotkD1PwzAQhj2ASinMTEie2FJ8ceIkbKjiSyoCIZgjx74orpLYxK5QVn45Ru10Nzzvo7uXkCtga2Asvd0Nk1lDWcadCRAnZAks5wmUrDgj597vGGNVleULsoAsEwBiSX43ctJGKjpgkI3tjR-oGamTweAYPP0xoaPa9DKgpnLUtJsdTmGyrjOKqv-wHWYb-W6-o9J79H6IyUPQTTbYMdGo7N710fCecKCvH9Q7VFHilXXzBTltZe_x8jhX5Ovx4XPznGzfnl4299vEAS9DArpq8qISaZ6xtoRCKdHEh0ArqbnQyHSZV6LASnLWNCmytGyrTAJikyPIlq_IzcEbr_reow_1YLzCvpcj2r2vC8654LyI4PUR3DcD6tpNZpDTXB9L43-JYnAr</recordid><startdate>199211</startdate><enddate>199211</enddate><creator>de Roos, A</creator><creator>Doornbos, J</creator><creator>Luyten, P R</creator><creator>Oosterwaal, L J</creator><creator>van der Wall, E E</creator><creator>den Hollander, J A</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>199211</creationdate><title>Cardiac metabolism in patients with dilated and hypertrophic cardiomyopathy: assessment with proton-decoupled P-31 MR spectroscopy</title><author>de Roos, A ; Doornbos, J ; Luyten, P R ; Oosterwaal, L J ; van der Wall, E E ; den Hollander, J A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p138t-1d9b57962540f817cc6b0001dcad36de0d85967e9a30bb2e028f94a1eeb5e1af3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1992</creationdate><topic>Adenosine Triphosphate - metabolism</topic><topic>Adult</topic><topic>Cardiomyopathy, Dilated - metabolism</topic><topic>Cardiomyopathy, Hypertrophic - metabolism</topic><topic>Diphosphoglyceric Acids - metabolism</topic><topic>Female</topic><topic>Humans</topic><topic>Magnetic Resonance Spectroscopy</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Myocardium - metabolism</topic><topic>Phosphates - metabolism</topic><topic>Phosphocreatine - metabolism</topic><topic>Reference Values</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>de Roos, A</creatorcontrib><creatorcontrib>Doornbos, J</creatorcontrib><creatorcontrib>Luyten, P R</creatorcontrib><creatorcontrib>Oosterwaal, L J</creatorcontrib><creatorcontrib>van der Wall, E E</creatorcontrib><creatorcontrib>den Hollander, J A</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of magnetic resonance imaging</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>de Roos, A</au><au>Doornbos, J</au><au>Luyten, P R</au><au>Oosterwaal, L J</au><au>van der Wall, E E</au><au>den Hollander, J A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cardiac metabolism in patients with dilated and hypertrophic cardiomyopathy: assessment with proton-decoupled P-31 MR spectroscopy</atitle><jtitle>Journal of magnetic resonance imaging</jtitle><addtitle>J Magn Reson Imaging</addtitle><date>1992-11</date><risdate>1992</risdate><volume>2</volume><issue>6</issue><spage>711</spage><epage>719</epage><pages>711-719</pages><issn>1053-1807</issn><abstract>Proton-decoupled phosphorus-31 heart spectroscopy was performed in healthy subjects (n = 9) and patients with dilated cardiomyopathy (DCM, n = 9) or hypertrophic cardiomyopathy (HCM, n = 8). The phosphocreatine (PCr)-to-adenosine triphosphate ratio (+/- one standard deviation) after correction for blood contribution and partial saturation was significantly lower in HCM patients relative to the control subjects (1.32 +/- 0.29 vs 1.65 +/- 0.26, P &lt; .05) but not in DCM patients (1.52 +/- 0.58 vs 1.65 +/- 0.26). The inorganic phosphate (Pi) peak was resolved only in patients with the highest spectral quality. Myocardial pH was lower in HCM patients (n = 6) relative to control subjects (n = 4) (7.07 +/- 0.07 vs 7.15 +/- 0.03, P &lt; .05). The Pi/PCr ratio was higher in DCM (n = 3) and HCM (n = 6) patients relative to control subjects (n = 4) (0.29 +/- 0.06 and 0.20 +/- 0.04, respectively, vs 0.14 +/- 0.06; P &lt; .05). Elevated phosphodiester signal in DCM patients correlated with 2,3-diphosphoglycerate signal (r = .94), reflecting blood pool contamination. P-31 spectroscopy enabled detection of abnormalities in cardiac metabolism and determination of pH in patients with HCM and DCM.</abstract><cop>United States</cop><pmid>1446116</pmid><doi>10.1002/jmri.1880020616</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1053-1807
ispartof Journal of magnetic resonance imaging, 1992-11, Vol.2 (6), p.711-719
issn 1053-1807
language eng
recordid cdi_proquest_miscellaneous_73336337
source MEDLINE; Wiley Journals
subjects Adenosine Triphosphate - metabolism
Adult
Cardiomyopathy, Dilated - metabolism
Cardiomyopathy, Hypertrophic - metabolism
Diphosphoglyceric Acids - metabolism
Female
Humans
Magnetic Resonance Spectroscopy
Male
Middle Aged
Myocardium - metabolism
Phosphates - metabolism
Phosphocreatine - metabolism
Reference Values
title Cardiac metabolism in patients with dilated and hypertrophic cardiomyopathy: assessment with proton-decoupled P-31 MR spectroscopy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T09%3A31%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cardiac%20metabolism%20in%20patients%20with%20dilated%20and%20hypertrophic%20cardiomyopathy:%20assessment%20with%20proton-decoupled%20P-31%20MR%20spectroscopy&rft.jtitle=Journal%20of%20magnetic%20resonance%20imaging&rft.au=de%20Roos,%20A&rft.date=1992-11&rft.volume=2&rft.issue=6&rft.spage=711&rft.epage=719&rft.pages=711-719&rft.issn=1053-1807&rft_id=info:doi/10.1002/jmri.1880020616&rft_dat=%3Cproquest_pubme%3E73336337%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=73336337&rft_id=info:pmid/1446116&rfr_iscdi=true